-
PPD Adds New Therapeutic Area Leaders
contractpharma
December 14, 2018
PPD has appointed Darell Heiselman, D.O., to lead cardiovascular and critical care and David Klein, M.D., Ph.D., to oversee endocrinology, metabolism and diabetes.
-
Constant Pharmaceuticals to Initiate Clinical Development of TXA127
americanpharmaceuticalreview
November 29, 2018
Constant Pharmaceuticals plans to begin a development program for its compound, TXA127, for the treatment of the rare pediatric disease, epidermolysis bullosa in collaboration with.....
-
Invion to spinout respiratory assets, advance clinical development in China
biospectrumasia
September 14, 2018
Invion completed feasibility, preclinical and clinical studies on its respiratory assets over three years to the end of 2015.
-
Vyome Biosciences appoints Angelo Secci as Chief Medical Officer
expressbpd
August 30, 2017
He will be responsible for leading Vyome’s clinical development, including the clinical programme of lead molecule, VB 1953, for the treatment of moderate to severe acne.